Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 21, 2016 - Issue 4
Submit an article Journal homepage
1,432
Views
47
CrossRef citations to date
0
Altmetric
Review

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

Francesco PanzaUnit of Neurodegenerative Disease, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, Italy;Unit of Neurodegenerative Disease, Department of Clinical Research in Neurology, University of Bari ‘Aldo Moro’ at ‘Pia Fondazione Card. G. Panico’, Lecce, Italy;Geriatric Unit and Gerontology-Geriatrics Research Laboratory, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, ItalyCorrespondence[email protected]
View further author information
,
Davide SeripaGeriatric Unit and Gerontology-Geriatrics Research Laboratory, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, ItalyView further author information
,
Vincenzo SolfrizziGeriatric Medicine-Memory Unit and Rare Disease Centre, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Bruno P. ImbimboResearch & Development Department, Chiesi Farmaceutici, Parma, ItalyView further author information
,
Madia LozuponeUnit of Neurodegenerative Disease, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Antonio LeoUnit of Neurodegenerative Disease, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Rodolfo SardoneBiomedical Engineering Unit, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Gaetano GagliardiUnit of Neurodegenerative Disease, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Lucia LofanoPsychiatric Unit, Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari ‘Aldo Moro’, Bari, ItalyView further author information
,
Bianca C. CreanzaInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Sacred Heart, Rome, ItalyView further author information
,
Paola BiscegliaGeriatric Unit and Gerontology-Geriatrics Research Laboratory, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, ItalyView further author information
,
Antonio DanieleInstitute of Neurology, Catholic University of Sacred Heart, Rome, ItalyView further author information
,
Antonello BellomoDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalyView further author information
,
Antonio GrecoGeriatric Unit and Gerontology-Geriatrics Research Laboratory, Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, ItalyView further author information
&
Giancarlo LogroscinoUnit of Neurodegenerative Disease, Department of Basic Medicine Sciences, Neuroscience, and Sense Organs, University of Bari ‘Aldo Moro’, Bari, Italy;Unit of Neurodegenerative Disease, Department of Clinical Research in Neurology, University of Bari ‘Aldo Moro’ at ‘Pia Fondazione Card. G. Panico’, Lecce, ItalyView further author information
 show all
Pages 377-391 | Received 24 Jun 2016, Accepted 22 Sep 2016, Published online: 06 Oct 2016

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Matthew R. Chapman, Weichen Zhou & Gregory Yeh. (2023) A Molecular Mechanism of Stress-Induced Alzheimer’s Disease; Part 1. Journal of Macromolecular Science, Part B 62:10, pages 543-556.
Read now
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Ping Kwan, Haruki Konno, Ka Yan Chan & Larry Baum. (2020) Rationale for the development of an Alzheimer’s disease vaccine. Human Vaccines & Immunotherapeutics 16:3, pages 645-653.
Read now
Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2018) The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opinion on Biological Therapy 18:1, pages 25-35.
Read now

Articles from other publishers (43)

Vaishali M. Patil, Neeraj Masand, Vertika Gautam, Shikha Kaushik & Dee Wu. 2023. Deciphering Drug Targets for Alzheimer’s Disease. Deciphering Drug Targets for Alzheimer’s Disease 285 319 .
Su-Ha Hwang, Su-Bin Park, Da-Young Yu, Jae-Yeon Cho, Won-Woo Lee, Mi-Ran Park, Jang-Won Lee & Yong-Deok Jeon. (2022) Neuroprotective Effect of the Mixture of Gastrodiae elata and Glycyrrhizae uralensis In Vitro. Applied Sciences 13:1, pages 190.
Crossref
Sotiria Liori, Angelos Arfaras-Melainis, Vasiliki Bistola, Eftihia Polyzogopoulou & John Parissis. (2021) Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations. Heart Failure Reviews 27:4, pages 993-999.
Crossref
Xiaoxin Wang, Hongru Sun, Sijia Pan, Xiao Bai, Zhuolin Zhu, Runan Zhang, Chunlong Li, Yang Chen, Meitong Bao, Kewei Zhang & Rennan Feng. (2022) Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study. Journal of Alzheimer's Disease 87:2, pages 665-673.
Crossref
Fredrik Blomgren, Alexander Rodin, Wojciech Chrobak, Dawid Wojciech Pacut, Jan Swenson & Inna Ermilova. (2022) Two statins and cromolyn as possible drugs against the cytotoxicity of Aβ(31–35) and Aβ(25–35) peptides: a comparative study by advanced computer simulation methods. RSC Advances 12:21, pages 13352-13366.
Crossref
Semira Abdi Beshir, A. M. Aadithsoorya, Affana Parveen, Sheron Sir Loon Goh, Nadia Hussain & Vineetha Bharathan Menon. (2022) Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review. International Journal of Alzheimer's Disease 2022, pages 1-10.
Crossref
Theresa H Page, Derick Chiappo, Francesca Brunini, Josep Garnica, Jack Blackburn, Fayaz Dudhiya, Maria Prendecki, Stephen P McAdoo & Charles D Pusey. (2022) Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses. Rheumatology 61:2, pages 834-845.
Crossref
Sylwia Król, Nicklas Österlund, Faraz Vosough, Jüri Jarvet, Sebastian Wärmländer, Andreas Barth, Leopold L. Ilag, Mazin Magzoub, Astrid Gräslund & Cecilia Mörman. (2021) The amyloid-inhibiting NCAM-PrP peptide targets Aβ peptide aggregation in membrane-mimetic environments. iScience 24:8, pages 102852.
Crossref
Ou Qiao, Haixia Ji, Yi Zhang, Xinyu Zhang, Xueqian Zhang, Na Liu, Luqi Huang, Changxiao Liu & Wenyuan Gao. (2021) New insights in drug development for Alzheimer's disease based on microglia function. Biomedicine & Pharmacotherapy 140, pages 111703.
Crossref
Jiahui Li, Kai Wang, Bo Huang, Rui Li, Xilong Wang, Hailing Zhang, Haixiong Tang & Xin Chen. (2021) The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model. International Immunopharmacology 93, pages 107419.
Crossref
Lijuan Yang, Yepei Liu, Yuanyuan Wang, Junsheng Li & Na Liu. (2021) Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway. Clinics 76, pages e2348.
Crossref
Yeonsoo Oh, Ha Thi Thu Do, Sunyoung Kim, Young-Mi Kim, Young-Won Chin & Jungsook Cho. (2020) Memory-Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action. Antioxidants 10:1, pages 34.
Crossref
Márcia Martins, Renata Silva, Madalena M. M. Pinto & Emília Sousa. (2020) Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease. Pharmaceuticals 13:9, pages 242.
Crossref
Zuzanna Angehrn, Jelena Sostar, Clementine Nordon, Andrew Turner, Dianne Gove, Helene Karcher, Alexander Keenan, Brent Mittelstadt & Frederic de Reydet-de Vulpillieres. (2020) Ethical and Social Implications of Using Predictive Modeling for Alzheimer’s Disease Prevention: A Systematic Literature Review. Journal of Alzheimer's Disease 76:3, pages 923-940.
Crossref
Marta Kowalska, Katarzyna Wize, Michał Prendecki, Margarita Lianeri, Wojciech Kozubski & Jolanta Dorszewska. (2020) Genetic Variants and Oxidative Stress in Alzheimer’s Disease. Current Alzheimer Research 17:3, pages 208-223.
Crossref
Damien Hall. (2020) A simple method for modeling amyloid kinetics featuring position biased fiber breakage. Biophysics and Physicobiology 17:0, pages 30-35.
Crossref
Miren Ettcheto, Oriol Busquets, Triana Espinosa-Jiménez, Ester Verdaguer, Carme Auladell & Antoni Camins. (2020) A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. Current Pharmaceutical Design 26:12, pages 1286-1299.
Crossref
Massimo De Martinis, Lia Ginaldi, Maria Maddalena Sirufo, Giovanni Pioggia, Gioacchino Calapai, Sebastiano Gangemi & Carmen Mannucci. (2020) Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review. Medicina 56:3, pages 138.
Crossref
Danfang Yu, Huanhuan Yan, Jun Zhou, Xiaodan Yang, Youming Lu & Yunyun Han. (2019) A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms. Molecular Neurodegeneration 14:1.
Crossref
Ee Wei Lim, Dag Aarsland, Dominic Ffytche, Raquel Natalia Taddei, Daniel J. van Wamelen, Yi-Min Wan, Eng King Tan & Kallol Ray Chaudhuri. (2018) Amyloid-β and Parkinson’s disease. Journal of Neurology 266:11, pages 2605-2619.
Crossref
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence J. O’Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman & Mohd. Farooq Shaikh. (2019) Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease. ACS Chemical Neuroscience 10:10, pages 4199-4212.
Crossref
Elena Tomaselli Muensterman, Yijia Luo & Jonathon M. Parker. (2019) Breakthrough Therapy, PRIME and Sakigake: A Comparison Between Neuroscience and Oncology in Obtaining Preferred Regulatory Status. Therapeutic Innovation & Regulatory Science, pages 216847901987406.
Crossref
Steve Pedrini, Mike Morici & Ralph N. Martins. 2019. Neurodegeneration and Alzheimer's Disease. Neurodegeneration and Alzheimer's Disease 391 442 .
Zuzanna Angehrn, Clementine Nordon, Andrew Turner, Dianne Gove, Helene Karcher, Alexander Keenan, Monika Neumann, Jelena Sostar & Frederic de Reydet de Vulpillieres. (2019) Ethical and social implications of using predictive modeling for Alzheimer’s disease prevention: a systematic literature review protocol. BMJ Open 9:3, pages e026468.
Crossref
Adam M Staffaroni, Peter A Ljubenkov, John Kornak, Yann Cobigo, Samir Datta, Gabe Marx, Samantha M Walters, Kevin Chiang, Nick Olney, Fanny M Elahi, David S Knopman, Bradford C Dickerson, Bradley F Boeve, Maria Luisa Gorno-Tempini, Salvatore Spina, Lea T Grinberg, William W Seeley, Bruce L Miller, Joel H Kramer, Adam L Boxer & Howard J Rosen. (2019) Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials. Brain 142:2, pages 443-459.
Crossref
Yunlong Zhang, Yangyang Huai, Xiaoning Zhang, Chuli Song, Jing Cai & Yingjiu Zhang. (2018) The Mode of Action of an Anti-Oligomeric Amyloid β-Protein Antibody Affects its Protective Efficacy. Neurotoxicity Research 35:2, pages 304-317.
Crossref
Lilian I. Plotkin, Alyson L. Essex & Hannah M. Davis. (2019) RAGE Signaling in Skeletal Biology. Current Osteoporosis Reports 17:1, pages 16-25.
Crossref
Francesco Panza, Madia Lozupone, Vittorio Dibello, Antonio Greco, Antonio Daniele, Davide Seripa, Giancarlo Logroscino & Bruno P Imbimbo. (2019) Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?. Immunotherapy 11:1, pages 3-6.
Crossref
Stella Gagliardi, Valentina Franco, Stefano Sorrentino, Susanna Zucca, Cecilia Pandini, Paola Rota, Stefano Bernuzzi, Alfredo Costa, Elena Sinforiani, Orietta Pansarasa, John R. Cashman & Cristina Cereda. (2018) Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease. Frontiers in Pharmacology 9.
Crossref
Vincenzo Solfrizzi, Pasquale Agosti, Madia Lozupone, Carlo Custodero, Andrea Schilardi, Vincenzo Valiani, Andrea Santamato, Rodolfo Sardone, Vittorio Dibello, Luca Di Lena, Roberta Stallone, Maurizio Ranieri, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa, Carlo Sabbà, Giancarlo Logroscino & Francesco Panza. (2018) Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review. Neuroscience & Biobehavioral Reviews 95, pages 480-498.
Crossref
Stephen M. Stahl. (2018) New hope for Alzheimer’s dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis. CNS Spectrums 23:5, pages 291-297.
Crossref
S.O. Bachurin, E.V. Bovina & A.A. Ustyugov. (2018) Current Trends in the Development of Drugs for the Treatment of Alzheimer’s Disease and their Clinical Trials. Biomedical Chemistry: Research and Methods 1:3, pages e00015.
Crossref
Sonya VanPatten & Yousef Al-Abed. (2017) High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target. Journal of Medicinal Chemistry 61:12, pages 5093-5107.
Crossref
Hyuck Jin Lee, Masha G. Savelieff, Juhye Kang, Megan Brunjes Brophy, Toshiki G. Nakashige, Shin Jung C. Lee, Elizabeth M. Nolan & Mi Hee Lim. (2018) Calprotectin influences the aggregation of metal-free and metal-bound amyloid-β by direct interaction. Metallomics 10:8, pages 1116-1127.
Crossref
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, Carlo Custodero, Vincenzo Valiani, Alessia D’Introno, Eleonora Stella, Roberta Stallone, Marco Piccininni, Antonello Bellomo, Davide Seripa, Antonio Daniele, Antonio Greco & Giancarlo Logroscino. 2018. Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases. Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases 139 155 .
Sally Hunter & Carol Brayne. (2017) Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?. Journal of Negative Results in BioMedicine 16:1.
Crossref
Talita P.C. Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, Carlos Requena, Victor Sebastian-Perez, Willian O. Castillo, Natalia C.S. Moreira, Concepción Pérez, Elza T. Sakamoto-Hojo, Catarina S. Takahashi, Jesús Jiménez-Barbero, F. Javier Cañada, Nuria E. Campillo, Ana Martinez & Ivone Carvalho. (2017) From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry 139, pages 773-791.
Crossref
Daniël H. van Raalte & C. Bruce Verchere. (2017) Improving glycaemic control in type 2 diabetes: S timulate insulin secretion or provide beta‐cell rest? . Diabetes, Obesity and Metabolism 19:9, pages 1205-1213.
Crossref
Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone, Bruno P. Imbimbo, Vincenzo Valiani, Pasquale Agosti, Andrea Schilardi, Alessia D’Introno, Maddalena La Montagna, Mariapaola Calvani, Vito Guerra, Rodolfo Sardone, Daniela I. Abbrescia, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa, Giancarlo Logroscino, Carlo Sabbá & Francesco Panza. (2017) Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review. Journal of Alzheimer's Disease 59:3, pages 815-849.
Crossref
Stephen M. Stahl. (2017) Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who’s listening?. CNS Spectrums 22:3, pages 247-250.
Crossref
Ingo Kilimann, Jochen René Thyrian, Wolfgang Hoffmann & Stefan J. Teipel. (2017) Translation of imaging biomarkers from clinical research to healthcareTranslation bildgebender Biomarker von klinischen Studien bis zur Gesundheitsversorgung. Zeitschrift für Gerontologie und Geriatrie 50:S2, pages 84-88.
Crossref
Michelle A. Puchowicz & Thomas N. Seyfried. (2017) Novel ketone body therapy for managing Alzheimer's disease. Journal of Neurochemistry 141:2, pages 162-164.
Crossref
Francesco Panza & Giancarlo Logroscino. (2017) Anti-tau vaccine in Alzheimer's disease: a tentative step. The Lancet Neurology 16:2, pages 99-100.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.